← k3vl4r
Log inGet started →

HRMY (Harmony Biosciences) Price Forecast

AI-generated price forecast for Harmony Biosciences (HRMY) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of August 2026: K3vl4r's AI model currently reads HRMY as split 1/1 across its horizons (1 of 2 timeframes pointing up), with a last price of 38.51. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

38.51

AI outlook

split 1/1

Timeframes up

1 / 2

Share𝕏PostTelegram

HRMY forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~6 weeks out———
Daily~4 months out▼ Down-18.74%0%
Weekly~1.9 years out▲ Up+0.79%—

Latest HRMY news

From the market-news feed the forecasts are read against.

  • Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline · Yahoo · Aug 14
  • Harmony Biosciences (HRMY) Q2 2026 Earnings Call Transcript · Motley Fool · Aug 11
  • ANIP Tops Q2 Earnings, Stock Down on Cortrophin Sales View Cut · Yahoo · Aug 10
  • Harmony Biosciences (HRMY) Is Up 9.0% After Q2 Earnings Jump And Pipeline Progress - What's Changed · Simply Wall St. · Aug 7
  • PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised · Yahoo · Aug 7

🔒

See the full HRMY forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

HRMY forecast — frequently asked

Will HRMY go up?

K3vl4r's AI model currently reads HRMY as split 1/1 — 1 of 2 forecast horizons point up, so the overall read is mixed. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the HRMY price prediction for 2026?

K3vl4r's model projects HRMY toward $38.76 over the next ~4 months, a -0.2% move from $38.83. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could HRMY reach?

Over its longest horizon (~~1.9 years), the model's projected target for HRMY is $38.20 (+0.0% vs $38.20). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

JNJBMYABBVGSKSNYPCRXMRKPRGOLLYNVORPRXAZNPFETEVA

Will HRMY reach…?

Will HRMY reach $50.00?Will HRMY reach $100.00?Will HRMY reach $200.00?Will HRMY reach $250.00?

Or see the full HRMY price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare HRMY

HRMY vs JNJHRMY vs BMYHRMY vs ABBVHRMY vs GSKHRMY vs SNYHRMY vs PCRX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.